Nuveen Asset Management, LLC Ptc Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 804,156 shares of PTCT stock, worth $31.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

804,156

Previous 686,525 17.13%

Holding current value

$31.5 Million

Previous $21 Million 42.11%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $3.57 Million - $4.43 Million	117,631 Added 17.13%	804,156 $29.8 Million
Q2 2024 Aug 09, 2024	BUY	$24.69 - $40.12 $5.43 Million - $8.82 Million	219,865 Added 47.11%	686,525 $21 Million
Q1 2024 May 13, 2024	BUY	$24.15 - $31.95 $4.21 Million - $5.57 Million	174,259 Added 59.6%	466,660 $13.6 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $1.5 Million - $2.43 Million	82,897 Added 39.57%	292,401 $8.06 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $39,889 - $74,742	-1,780 Reduced 0.84%	209,504 $4.69 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $82,092 - $120,091	2,032 Added 0.97%	211,284 $8.59 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $537,712 - $688,486	14,091 Added 7.22%	209,252 $10.1 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $543,487 - $888,091	-16,209 Reduced 7.67%	195,161 $7.45 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $111,404 - $143,348	-2,662 Reduced 1.24%	211,370 $10.6 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $1.66 Million - $2.94 Million	-64,891 Reduced 23.26%	214,032 $8.57 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $2.38 Million - $3.19 Million	71,502 Added 34.47%	278,923 $5.79 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $1.27 Million - $1.5 Million	-35,905 Reduced 14.76%	207,421 $4.3 Million
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $338,752 - $409,505	-9,153 Reduced 3.63%	243,326 $5.05 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $60,150 - $78,251	1,585 Added 0.63%	252,479 $5.24 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $337,942 - $497,671	-7,221 Reduced 2.8%	250,894 $5.21 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $139,755 - $197,102	-2,914 Reduced 1.12%	258,115 $5.36 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $1.22 Million - $1.53 Million	-26,837 Reduced 9.32%	261,029 $5.42 Million
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $10.8 Million - $14 Million	-254,368 Reduced 46.91%	287,866 $5.97 Million
Q1 2020 May 14, 2020	SELL	$32.37 - $59.36 $3.82 Million - $7 Million	-117,857 Reduced 17.85%	542,234 $24.2 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $11.8 Million - $18.3 Million	365,512 Added 124.08%	660,091 $31.7 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $521,977 - $743,455	15,434 Added 5.53%	294,579 $9.96 Million
Q2 2019 Aug 15, 2019	BUY	$35.42 - $45.0 $9.89 Million - $12.6 Million	279,145 New	279,145 $12.6 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ptc Therapeutics, Inc. Transaction History